Roivant Sciences (ROIVW) Stock Analysis
NASDAQHealthcareBiotechnology
What Roivant Sciences does
Roivant Sciences Ltd. operates as a biopharmaceutical and healthcare technology enterprise, concentrating on the research and development of innovative pharmaceutical solutions. The firm's pipeline features investigational therapies aimed at a diverse range of diseases. These include various oncologic malignancies (such as solid tumors), blood conditions like sickle cell disease, rare genetic disorders such as hypophosphatasia, and a spectrum of dermatological ailments including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, and acne. Additionally, their work extends to autoimmune disorders like myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, and sarcoidosis, alongside bacterial infections such as Staph aureus bacteremia. Founded in 2014, the company maintains its headquarters in London, United Kingdom.
Key metrics
ETFs linked to ROIVW
Broad-market and Healthcare sector ETFs an investor holding Roivant Sciences is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ROIVW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ROIVW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Roivant Sciences?
- Roivant Sciences trades under the ticker ROIVW on NASDAQ.
- Which exchange is ROIVW listed on?
- ROIVW is listed on NASDAQ.
- What sector does Roivant Sciences operate in?
- Roivant Sciences is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze ROIVW in a portfolio?
- PortView shows ROIVW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.